Live News

Journals & Papers, Articles
NEJM Nephrology 新英格兰-肾病
New Creatinine- and Cystatin C–Based Equations to Estimate GFR without Race
Abstract Background Current equations for estimated glomerular filtration rate (eGFR) that use serum creatinine or cystati...
Cardiovascular and Renal Outcomes with Efpeglenatide in Type 2 Diabetes
Original Article from The New England Journal of Medicine — Cardiovascular and Renal Outcomes with Efpeglenatide in ...
Moving the Goalposts for Blood Pressure — Time to Act
We often lament the lack of confirmatory studies that can either reassure us all that the previous evidence for a trialed ...
Trial of Intensive Blood-Pressure Control in Older Patients with Hypertension
Original Article from The New England Journal of Medicine — Trial of Intensive Blood-Pressure Control in Older Patie...
SGLT2 Inhibition in Heart Failure with a Preserved Ejection Fraction — A Win against a Formidable Foe
More Evidence for SGLT2 Inhibitors in Heart Failure Mark Drazner comments on the findings of the EMPEROR-Preserved trial, ...
Empagliflozin and Major Renal Outcomes in Heart Failure
Correspondence from The New England Journal of Medicine — Empagliflozin and Major Renal Outcomes in Heart Failure
The Promise of Adjuvant Immunotherapy in Renal-Cell Carcinoma
Renal-cell carcinoma is a common cancer in both men and women around the world. Although nephrectomy remains the standard ...
Adjuvant Pembrolizumab after Nephrectomy in Renal-Cell Carcinoma
Abstract Background Patients with renal-cell carcinoma who undergo nephrectomy have no options for adjuvant therapy to red...
Three Doses of an mRNA Covid-19 Vaccine in Solid-Organ Transplant Recipients
Three Covid-19 Vaccine Doses in Transplant Recipients Solid-organ transplant recipients receiving immunosuppressive therap...
Load More
format_indent_increase